Product Details
Product Name:
CDC801 |
CAS No.:
192819-27-5 |
Purity:
98.81% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | CDC801 |
Description | CDC801 is an inhibitor of PDE4 and TNF-α with IC50s of 1.1 μM and 2.5 μM, respectively. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 4.08 mg/mL (9.99 mM)
|
Keywords | CDC801 | CDC 801 |
Inhibitors Related | Acetylcysteine | Theophylline monohydrate | Glucosamine | Theobromine | Apremilast | Isoprenaline hydrochloride | Indomethacin | Lenalidomide | Fisetin | Icariin | Theophylline | Doxofylline |
Related Compound Libraries | NF-κB Signaling Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1165-39-5
$232.00 / 1mg
-
CAS:66640-93-5
$1520.00 / 25mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$173.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |